ArticleIDCases2026
Bacillus subtilis var. natto bacteremia: A case series and review.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natto, a traditional Japanese fermented soybean food, contains Bacillus subtilis var. natto, which is generally regarded as safe but can rarely cause bloodstream infections in susceptible individuals. We report three cases of B. subtilis var. natto bacteremia confirmed by biotin operon analysis: a 63-year-old man receiving maintenance hemodialysis, a 35-year-old woman at 36 weeks of gestation, and a 62-year-old man whose bacteremia led to the diagnosis of colorectal cancer. All patients reported habitual natto consumption and had underlying conditions associated with impaired intestinal barrier function or altered immune status. Blood cultures yielded Bacillus subtilis, which was initially regarded as a contaminant. Targeted antimicrobial therapy resulted in resolution of bacteremia in all patients; the pregnant patient underwent emergency cesarean delivery, and the third patient subsequently underwent surgical resection for colorectal cancer. When considered together with previously published cases, our findings suggest that B. subtilis var. natto bacteremia primarily occurs in patients with impaired host defenses or intestinal barrier dysfunction. Biotin operon analysis identified characteristic genetic features of B. subtilis var. natto, consistent with a likely dietary origin associated with natto consumption. Because Bacillus species isolated from blood cultures are often dismissed as contaminants, B. subtilis var. natto bacteremia is likely underrecognized. Clinicians should consider this diagnosis in patients with relevant risk factors and obtain a detailed dietary history when Bacillus species are isolated from blood cultures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.